Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma
PurposeTo develop a prognosis nomogram for locally advanced esophageal squamous cell carcinoma (LA-ESCC) patients after neoadjuvant immunochemotherapy (NICT) and assess postoperative adjuvant therapy (PAT) value through survival risk stratification.MethodsWe retrospectively analyzed 297 LA-ESCC pati...
Saved in:
| Main Authors: | Qiuying An, Hongyan Wang, Hui Zhu, Yage Jia, Yibing Liu, Zheng Liu, Jin Yan, Zihan Zhang, Yajing Wang, Ping Zhang, Zhiguo Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1621607/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
by: Jifeng Feng, et al.
Published: (2024-12-01) -
Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety
by: Xiaomin Wang, et al.
Published: (2025-04-01) -
Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy
by: Qiang Zhao, et al.
Published: (2025-08-01) -
Neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study with 2-year survival analysis
by: Chong-Rui Li, et al.
Published: (2025-07-01) -
Neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice: an analysis of the clinical outcomes and long-term survival, and the feasibility of using major pathological response as a surrogate endpoint
by: Jiacong Liu, et al.
Published: (2025-04-01)